Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Fulvestrant
Related studies linked through entity extraction aliases.
A Single Arm, Tolerability and Safety Phase IV Study of Fulvestrant(Faslodex® ) as 2nd Line and Later Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE4
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment.
- Status
- COMPLETED
- Phase
- PHASE3
Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE3
Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Overcoming Endocrine Resistance in Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alobresib (Formerly GS-5829) in Adults With Advanced Solid Tumors and Lymphomas and in Combination With Exemestane or Fulvestrant in Adults With Estrogen Receptor Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Study of the Combination of MLN9708 and Fulvestrant
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fulvestrant as Maintenance Therapy After First-line Chemotherapy in HER2 - Postmenopausal MBC Patients
- Status
- UNKNOWN
- Phase
- PHASE3
Study to Assess the Efficacy and Safety of the Epigenetic Modifying Effects of CC-486 (Oral Azacitidine) in Combination With Fulvestrant
- Status
- TERMINATED
- Phase
- PHASE2
Detect V / CHEVENDO (Chemo vs. Endo)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy
- Status
- TERMINATED
- Phase
- PHASE3
A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Everolimus Beyond Progression
- Status
- TERMINATED
- Phase
- PHASE2
Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE1
A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Endocrine Response in Women With Invasive Lobular Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABC
- Status
- WITHDRAWN
- Phase
- PHASE2